GCC-Countries Mice Model Market Size, Share,Trends, Growth Analysis Report, 2030

Overview Request Sample Pages Request Customization Download PDF

You are viewing: GCC Countries Mice Model Market analysis

Part of: Mice Model Market (Global)

The GCC Countries Mice Model Market was valued at $0.17 Million in 2025 and projected to reach to $0.24 Million by 2030, representing a compound annual growth rate of 6.5%. The GCC Countries mice model market is positioned for steady expansion as regional governments prioritize biomedical research and pharmaceutical innovation.

GCC Countries Mice Model Market (2025-2030) : Size and Share

CAGR of

USD Million

GCC Countries Mice Model Market Trends and Insights

GCC Countries represents a developing segment within the broader Middle East healthcare research landscape, driven by increasing investment in biomedical research infrastructure and pharmaceutical development initiatives.
The 6.5% compound annual growth rate reflects GCC Countries' commitment to advancing preclinical research capabilities and establishing regional research hubs. GCC Countries' mice model market is supported by growing adoption of in vivo research models across academic institutions and contract research organizations.
The expansion of healthcare spending and regulatory frameworks in GCC Countries is creating favorable conditions for laboratory animal model procurement and breeding facilities.
Between 2025 and 2030, GCC Countries is expected to see enhanced demand from pharmaceutical companies and research centers seeking standardized, disease-specific mouse models for drug development and safety testing. The market trajectory in GCC Countries reflects broader regional trends toward self-sufficiency in preclinical research and reduced dependency on imported research models.
Strategic partnerships between GCC Countries-based institutions and international research organizations are facilitating knowledge transfer and market maturation in this specialized healthcare segment..

Key Market Statistics

CAGR (2025-2030) 6.5% CAGR
Market Size, 2025 ~USD 0.17 Million
Forecast, 2030 ~USD 0.24 Million
Country GCC Countries

GCC Countries Mice Model Market Overview

Market Size & Growth :

GCC Countries mice model market valued at $0.17 million in 2025, expanding to $0.24 million by 2030 at a 6.5% CAGR, reflecting steady regional adoption of preclinical research models.

Regional Research Infrastructure :

GCC nations are investing significantly in biomedical research facilities and pharmaceutical development centers, creating increased demand for standardized mice models in drug discovery and toxicology studies.

Pharmaceutical Development Focus :

Growing pharmaceutical manufacturing and R&D initiatives across GCC Countries are driving adoption of mice models for regulatory compliance and efficacy testing in line with international standards.

Emerging Market Opportunity :

As a developing segment within Middle East healthcare research, GCC Countries presents untapped potential for suppliers and research institutions seeking to establish presence in Gulf region biomedical markets.

GCC Countries Mice Model Market Dynamics

Increased funding for research institutions, coupled with growing pharmaceutical manufacturing capabilities, will drive demand for laboratory mice models.
The 6.5% CAGR reflects moderate but consistent growth as GCC nations align with global research standards and establish themselves as regional innovation hubs. Future growth will be supported by collaborations between GCC research centers and international pharmaceutical companies, regulatory requirements for drug testing, and investments in life sciences infrastructure.
However, market penetration remains limited compared to global averages, presenting significant opportunity for market development and supplier expansion in the coming years..

Related Ecosystem

Biotechnology

Top Technologies

Reagents
Polymerase Chain Reaction (PCR)
Stem Cells
Assay Kits
Flow Cytometers

Top Companies

Thermo Fisher Scientific Inc.
Merck KGaA
Danaher Corporation
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.

Key Takeaways

GCC Countries mice model market valued at $0.17M in 2025, growing to $0.24M by 2030 at 6.5% CAGR
GCC Countries is investing heavily in biomedical research infrastructure and preclinical research capabilities
Pharmaceutical and academic institutions in GCC Countries are increasing demand for standardized disease-specific mouse models
GCC Countries is transitioning toward regional self-sufficiency in laboratory animal model supply and breeding

Mice Model Market Report Scope

Report Metric	Details
Base Year	2025
Fastest Growing Segment	SERVICES (Model Type & Service)
Forecast Period	2025�2030
Growth Rate	CAGR of 10% from 2025 to 2030
Largest Segment	MODEL TYPE (Model Type & Service)
Market Size Base Year (Billions)	~USD 1.7 (2025)
Revenue Forecast (Billions)	~USD 2.74 (2030)
Segments Covered	Model Type & Service, Type, Technology, Application, Therapeutic Area, End User

GCC Countries Mice Model Market Report Segmentation

6 segment dimensions are covered across the global market.

By Model Type & Service

Model Type
Services

By Type

Breeding Services
Cryopreservation Services
Genetically Engineered Mice
Hybrid/Congenic Mice
Inbred Mice
Other Services
Outbred Mice
Quarantine Services
Rederivation Services

By Technology

Crispr/Cas9
Embryonic Stem Cell Injections
Microinjections
Nuclear Transfer Technique
Other Technologies

By Application

Drug Discovery & Development
Personalized Medicine
Research Applications

By Therapeutic Area

Cardiovascular Diseases
Immunology
Metabolic Diseases
Neurology
Oncology
Other Therapeutic Areas

By End User

Academic & Research Institutes
Contract Research Organizations (Cros) & Contract Development And Manufacturing Organizations (Cdmos)
Pharmaceutical & Biotechnology Companies

Target Audience

Pharmaceutical Companies : GCC-based and international pharma firms need market data to plan R&D investments, establish preclinical testing capabilities, and navigate regional regulatory requirements for drug development.
Research Institutions : Universities and biomedical research centers in GCC Countries require market insights to secure funding, justify laboratory investments, and benchmark their research infrastructure against regional peers.
Laboratory Animal Suppliers : Vendors of mice models and breeding facilities need GCC-specific demand forecasts to optimize supply chain, plan facility expansion, and identify distribution opportunities in Gulf markets.
Healthcare Investors : Private equity and venture capital firms evaluating biomedical investments in GCC region need market sizing and growth projections to assess portfolio opportunities and funding decisions.
Government & Policy Makers : GCC health ministries and research councils use market data to inform science policy, allocate research budgets, and develop strategies for regional biomedical innovation hubs.

Key Companies in the GCC Countries Mice Model Market

Company	HQ	Ownership	Strongest segments
HORIZON DISCOVERY GROUP PLC	United Kingdom	Private Company	Screening,Research Reagents,Diagnostics,
LABORATORY CORPORATION OF AMERICA HOLDINGS	United States	Public Company	Routine and wellness diagnostics (chemistry, hematology, urinalysis, wellness programs),Specialty and esoteric testing (gene-based, oncology, infectious disease, women�s health, pharmacogenetics),Biopharma Laboratory Services (clinical trial, central lab, medical device and diagnostic R&D),
CHARLES RIVER LABORATORIES	United States	Public Company	Discovery and Safety Assessment,Research Models and Services,Manufacturing Solutions,
THE JACKSON LABORATORY	United States	Foundation/Charitable Institution	Mouse breeding and colony management services,Cryopreservation, recovery, and genetic resource management,Phenotyping, efficacy testing, and study-ready induced models,
INOTIV	United States	Public Company	Research Models and Services (RMS),Discovery and Safety Assessment (DSA) Services,BASi Scientific Instruments and Software,
JSR CORPORATION	Japan	Private Company	Digital Solutions (lithography, photoresists, packaging, CMP, display materials),Plastics (synthetic resins: ABS, AES, AS, ASA),Life Sciences (diagnostic reagents, bioprocess materials, drug discovery support),
BIOCYTOGEN	China	Public Company	Gene-Editing Services,Pharmacological Efficacy & Toxicology Services,Model Animals (Breeding & Sales),
SHANGHAI MODEL ORGANISMS CENTER, INC.	China	Public Company	Standard and disease mouse models (including toolbox and disease-specific strains),Customized genetically engineered models (KO, KI, humanized, transgenic),Preclinical services (non-GLP tox, PK, pharmacology/PD, phenotype analysis),
TRANS GENIC INC.	Japan	Public Company	Drug Discovery Support (non-clinical, bioequivalence, safety tests),Transgenic Models & Reagents (GM mice, antibodies, proteins, cells),Glycan Synthesis & Sugar Chain Analysis,
HARBOUR BIOMED	China	Public Company	Harbour Mice platform licensing and collaborations,Immunology clinical assets (e.g., batoclimab, HBM7020, HBM9378),Oncology clinical assets (e.g., porustobart, solid tumor portfolio),
GENOWAY	France	Public Company	Custom KO/KI mouse models,Custom KO/KI rat models,Humanized and immunodeficient rodent models (catalog and custom),
GEMPHARMATECH	China	Public Company	Standard GEMM catalog (knockout, conditional, knock-in, point-mutation, transgenic),Custom model generation and tool mice,Preclinical testing services,
VIVO BIO TECH LTD.	India	Public Company	In vivo and in vitro toxicity, PK/TK, and pharmacology services,SPF lab animals, rodent breeding, custom models, and lab diets,Genotoxicity screening and analytical services,

HORIZON DISCOVERY GROUP PLC

Horizon Discovery Group PLC is a United Kingdom-based private company founded in 2005 with 428 employees. The company operates in the life sciences sector, providing specialized research and development services.

LABORATORY CORPORATION OF AMERICA HOLDINGS

Laboratory Corporation of America Holdings is a major United States public company founded in 1995 with 66,385 employees. It is a leading provider of clinical laboratory services and drug development support.

CHARLES RIVER LABORATORIES

Charles River Laboratories is a United States public company founded in 1947 with 19,000 employees. The company provides preclinical and clinical laboratory services, research models, and safety assessment services.

THE JACKSON LABORATORY

The Jackson Laboratory is a United States foundation and charitable institution founded in 1929 with 2,100 employees. It is a premier research institution specializing in mammalian genetics and genomics.

INOTIV

Inotiv is a United States public company founded in 1974 with 1,996 employees. The company provides research models, services, and products for the pharmaceutical and biotechnology industries.

JSR CORPORATION

JSR Corporation is a Japan-based private company founded in 1948 with 7,997 employees. The company operates in advanced materials and life sciences sectors.

BIOCYTOGEN

Biocytogen is a China-based public company founded in 2008 with 1,443 employees. The company specializes in the development of genetically engineered animal models for research and drug development.

SHANGHAI MODEL ORGANISMS CENTER, INC.

Shanghai Model Organisms Center, Inc. is a China-based public company founded in 2000 with 848 employees. The company provides model organism services and products for biomedical research.

TRANS GENIC INC.

Trans Genic Inc. is a Japan-based public company founded in 1998 with 227 employees. The company develops and provides transgenic animal models for research applications.

HARBOUR BIOMED

Harbour Biomed is a China-based public company founded in 2016 with 272 employees. The company focuses on antibody and immunotherapy research and development.

GENOWAY

Genoway is a France-based public company founded in 1999 with 157 employees. The company specializes in the generation of genetically modified animal models for research.

GEMPHARMATECH

GemPharmatech is a China-based public company founded in 2017 with 1,590 employees. The company provides laboratory animal models and related research services.

VIVO BIO TECH LTD.

Vivo Bio Tech Ltd. is an India-based public company founded in 1987 with 174 employees. The company provides contract research services and laboratory animal models for pharmaceutical and biotechnology research.

Reasons to Buy this Report

Regional Market Intelligence : Gain specific insights into GCC Countries market dynamics, growth drivers, and competitive landscape distinct from broader Middle East or global market analyses.
Investment & Expansion Planning : Identify market entry opportunities and growth potential in GCC nations with quantified market size projections and CAGR data for strategic business planning.
Supplier & Partnership Strategy : Understand demand patterns specific to GCC research institutions and pharmaceutical companies to tailor product offerings and establish regional distribution partnerships.
Competitive Positioning : Benchmark your organization against regional market trends and identify gaps in GCC Countries market coverage to differentiate offerings and capture emerging opportunities.
Regulatory & Compliance Insights : Access region-specific information on research standards, pharmaceutical development requirements, and regulatory drivers influencing mice model adoption in GCC nations.

Frequently asked questions

What is the current market size of mice models in GCC Countries?

The mice model market in GCC Countries was valued at $0.17 million in 2025 and is projected to reach $0.24 million by 2030.

What is the growth rate for the mice model market in GCC Countries?

GCC Countries' mice model market is expected to grow at a compound annual growth rate (CAGR) of 6.5% from 2025 to 2030.

Which sectors are driving demand for mice models in GCC Countries?

Pharmaceutical companies, contract research organizations, and academic research institutions in GCC Countries are the primary drivers of mice model demand for drug development and preclinical testing.

Why is GCC Countries investing in mice model research capabilities?

GCC Countries is building regional research infrastructure and reducing dependency on imported research models to support local pharmaceutical development and biomedical research initiatives.

What types of mice models are most in demand in GCC Countries?

Disease-specific and genetically modified mouse models are increasingly sought by research institutions and pharmaceutical companies in GCC Countries for drug efficacy and safety testing.

RESEARCH METHODOLOGY

This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global mice model market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

Secondary Research

Secondary research was used primarily to identify & collect information for the extensive, technical, market-oriented, and commercial study. The secondary sources used for this study include the International Mouse Phenotyping Consortium (IMPC), Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC), European Molecular Biology Laboratory−European Bioinformatics Institute (EMBL-EBI), Swiss Laboratory Animal Science Association (SGV), Medical Research Council (MRC), Asian Mouse Mutagenesis Resource Association (AMMRA), Department of Biotechnology (DBT) (India), World Health Organization (WHO), United States Food and Drug Administration (US FDA), Annual Reports, SEC Filings, Investor Presentations, Research Journals, Press Releases, and financial statements. These sources also obtained key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

Primary Research

In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative & quantitative information and assess the prospects of the market. Various primary sources from both the supply & demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:

The following is a breakdown of the primary respondents:

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate & validate the total size of the mice model market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

Data Triangulation

The total market was split into several segments and subsegments after arriving at the overall market size from the estimation process. Where applicable, data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

An animal model is a valuable resource in biomedical research, chosen for its ability to replicate certain aspects of biological processes or diseases observed in humans. A mouse model is a genetically engineered or naturally occurring mouse strain used in biomedical research to mimic human diseases or conditions. These models are valuable for their biological similarity to humans, ability to be genetically manipulated, and cost-effectiveness, enabling researchers to study disease mechanisms and test novel drug therapies efficiently. Mice share over 95% of human DNA and are biologically similar to humans, thereby being susceptible to similar diseases due to the genetic build-up.

Stakeholders

Manufacturers & Distributors of Mice Models
CROs & CDMOs
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Market Research & Consulting Firms
Researchers & Scientists
Regulatory Authorities & Institutes

Report Objectives

To define, describe, and forecast the global mice model market based on model type & service, technology, therapeutic area, application, product end user, service end user, and region
To provide detailed information regarding the leading factors driving the growth of the market (such as drivers, restraints, challenges, and opportunities)
To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall mice models market
To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
To forecast the size of the market segments with respect to six regions: North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
Track & analyze competitive developments such as acquisitions, product launches, expansions, agreements, partnerships, and R&D activities in the mice models market.
To analyze and provide funding & investment activities, brand/product comparative analysis, and vendor valuation & financial metrics of the mice model market.

Get the Full Mice Model Market Report

Full forecast, segment splits, and company analysis for all Mice Model Market.

Download Sample Pages Buy Report

REPORT COVERAGE

＋

Report Description
Market Overview
Market Dynamics
Related Ecosystem
Key Takeaways
Market Scope
Report Segmentation
Target Audience
Key Companies

Market Size in	USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered	Value (USD MN)